Segmental analysis of molecular surface electrostatic potentials: application to enzyme inhibition

Area of Science:

• Medicinal Chemistry
• Computational Chemistry
• Drug Discovery

Background:

• Previous research established quantitative relationships between anti-HIV activity of reverse transcriptase inhibitors and molecular electrostatic potentials.
• Understanding drug-target interactions is crucial for developing effective antiviral therapies.

Purpose of the Study:

• To introduce and evaluate a novel technique using molecular segments for quantitative structure-activity relationship (QSAR) studies of anti-HIV drugs.
• To determine if analyzing specific drug segments enhances predictive models compared to whole-molecule analysis.

Main Methods:

• Application of segmental analysis to three drug families: two targeting HIV reverse transcriptase and one targeting HIV protease.
• Quantitative analysis of electrostatic potentials on molecular surfaces of drug segments.
• Comparison of correlation coefficients between whole-molecule and segmental analyses.

Main Results:

• Segmental analysis significantly improved correlations in one case and moderately in another, suggesting key roles for specific molecular regions.
• In one instance, segmental analysis negatively impacted correlations, indicating the importance of the entire molecule's surface in drug interaction.
• The study demonstrated variable outcomes depending on the drug class and target.

Conclusions:

• Segmental analysis is a valuable exploratory tool providing insights into drug-target interactions and the significance of specific molecular regions.
• This technique can potentially enhance the predictive power of QSAR models for antiviral drug development.
• The findings highlight the need to consider both specific segments and entire molecules in drug design, depending on the interaction mechanism.